Clinical Trials

100 enrolled

BreastLymphoid

Breast Neoplasms, Heart Failure, Lymphoma, Cardiotoxicity

NCT05728632 2023-02-23

CONTROL

Phase 3 Unknown

80 enrolled

BreastLymphoid

Breast Neoplasms, Lymphoma, Large B-Cell, Diffuse, Ventricular Dysfunction, Left, Cardiotoxicity

NCT05733026 2023-02-17

Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients

200 enrolled

Breast Neoplasms, Cardiotoxicity

NCT02942615 2022-12-29

The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.

220 enrolled

Breast Neoplasms, Cardiotoxicity

NCT05454553 2022-11-29

EDIPE

58 enrolled

Breast Neoplasms, Cardiotoxicity

NCT05595109 2022-10-26

Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients

Phase 2/3 Unknown

56 enrolled

Breast Neoplasms, Peripheral Nervous System Diseases, Cognitive Dysfunction, Cardiotoxicity

NCT05146843 2022-04-08

The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients

44 enrolled

Breast Neoplasms, Cardiotoxicity

NCT05298072 2022-03-28

Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients

180 enrolled

Breast Neoplasms, Heart Failure, Cardiotoxicity

NCT02236806 2022-02-01

SAFE

Phase 3 Unknown

262 enrolled

Breast Neoplasms, Cardiotoxicity

NCT05040867 2021-09-10

Exercise Prescription Guided by Heart Rate Variability in Breast Cancer Patients

90 enrolled

Breast Neoplasms, Motor Activity, Cardiotoxicity

NCT05019365 2021-08-24

Investigating the Long-term Cardiac Sequelae of Trastuzumab Therapy

60 enrolled

Breast Neoplasms, Cardiotoxicity

NCT04962425 2021-07-15

Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients

240 enrolled

Breast Neoplasms, Cardiotoxicity

NCT04961307 2021-07-14

Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab

30 enrolled

Breast Neoplasms, Cardiotoxicity

NCT04429633 2020-06-12

Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer

136 enrolled

Breast Neoplasms, Cardiotoxicity

NCT04046315 2020-03-16

EARLY-CATCH

55 enrolled

Breast Neoplasms, Cardiotoxicity

NCT03155802 2019-11-01

Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines

35 enrolled

Breast Neoplasms, Heart Failure, Cardiotoxicity

NCT02571894 2018-03-07

COBC

320 enrolled

Breast Neoplasms, Cardiomyopathies, Cardiotoxicity

NCT01022086 2017-07-12

Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab

50 enrolled

Breast Neoplasms, Neoplasm Metastasis, Cardiotoxicity

NCT02052102 2017-01-06

Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart

Phase 2 Unknown

63 enrolled

Unilateral Breast Neoplasms, Breast Neoplasms, Radiation Injuries, Cardiotoxicity

NCT01016886 2016-02-09

MANTICORE

Phase 1/2 Unknown

99 enrolled

Breast Neoplasms, Heart Failure, Cardiotoxicity

NCT02101879 2014-05-02

Cardiotoxicity in Metastatic Her 2 Positive Patients Treated With Trastuzumab ,Pertuzumab and Taxanes

20 enrolled

Breast Neoplasms, Cardiotoxicity

NCT01246856 2011-09-12

TOXTAC

150 enrolled

Breast Neoplasms, Cardiotoxicity

NCT01093235 2010-03-25

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

Phase 3 Unknown

800 enrolled